NCT01339481 - A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

abatacept

Intravenous Infusion

Trial Locations (7)

North Shore - Long Island Jewish Health System, Lake Success

Altoona Center for Clinical Research, Duncansville

The Center for Rheumatology and Bone Research, Wheaton

Low County Rheumatology, North Charleston

Arthritis Research of Florida, Palm Harbor

Pinnacle Research Group, LLC, Anniston

Metroplex Clinical Research Center, Dallas